Neurodegenerative disorders Flashcards

1
Q

what characterizes the deficits in Alzheimer’s disease?

A

loss of hippocampal and cortical neurons resulting in impaired memory formation and cognitive deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what characterizes the deficits in parkinson’s disease and huntington’s disease?

A

loss of dopaminergic neurons in basal ganglia leading to altered movement control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what characterizes the deficits in amyotrophic lateral sclerosis?

A

degeneration of cortical and spinal motor neurons resulting in muscular weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the protein accumulations associated with AD?

A

extracellular beta amyloid and intracytoplasmic neurofibrillary tangles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the protein accumulations associated with ALS and parkinsons?

A

intracytoplasmic aggregates

PD - alpha synuclein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the protein accumulations associated with huntingtons?

A

intranuclear inclusions of huntingtin protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the cognitive symptoms associated with AD?

A
loss of short term memory 
aphasia 
apraxia (inability to carry out motor activities) 
agnosia 
disorientation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the noncognitive symptoms associated with AD?

A

depression, psychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the cholinergic hypothesis of AD?

A

deficiency in Ach due to degeneration of subcortical cholinergic neurons (memory formation areas - hippocampus)

PRIMARY PATHOGENESIS HYPOTHESIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the amyloid hypothesis of AD?

A

extracellular accumulations of beta amyloid peptides (BA) are toxic to neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

does deposition of BA plaques correlate with neuronal loss?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

early onset AD is associated with mutations in what genes? what is the result?

A

APP, PSEN1, PSEN2

overproduction of AB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the role of PSEN1 and PSEN2?

A

encode for membrane proteins involved in cleaving APP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the role of APP?

A

encodes amyloid B precursor peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the tau hypothesis in AD?

A

hyperphosphorylation of tau forms aggregates and neurofibrillary tangles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the result of tau hyperphosphorylation?

A

microtubular disintegration and instability
collapse of neuronal transport system
altered NT release and synaptic function
cell death

17
Q

what is the first line therapy for symptomatic treatment of cognitive impairments in mild to moderate AD? does it modify the progression?

A

cholinesterase inhibitors

no

18
Q

what is the MOA of the cholinesterase inhibitors?

A

reduce breakdown of endogenously released Ach, resulting in greater activation of postsynaptic Ach receptors

19
Q

what are the cholinesterase inhibitor agents for AD?

A

tacrine
donepezil
rivastigmine
galantamine

20
Q

donepezil inhibits primarily what enzyme?

21
Q

what is the MOA of rivastigmine?

A

inhibits AchE and BchE

22
Q

which AD agent appears selective for hippocampus and prefrontal cortex?

A

rivastigmine

23
Q

what is the route for rivastigmine?

A

transdermal pouch

24
Q

what are the cholinergic side effects of cholinesterase inhibitors?

A

SLUDGE

salivation 
lacrimation 
urinary incontinence 
diarrhea 
GI cramps 
emesis
25
what is the main side effect associated with donepezil?
bradycardia
26
what is the glutamate antagonist agent for AD?
memantine
27
what is the MOA of memantine?
non-competitive antagonist of the NMDA glutamate receptor with long half life provides neuroprotection by reducing intracellular calcium influx and glutamate induced neurotoxicity
28
which hormone is used as replacement therapy in women with AD?
estrogen
29
what is the main treatment options for the psychotic symptoms associated with AD?
atypical antipsychotics risperidone, olanzapine, quetiapine
30
what is the main treatment options for the depression symptoms associated with AD?
SSRIs sertraline, citalopram
31
which drugs should be avoided in treating the depression associated with AD? why?
TCAs side effects - anticholinergic affects, orthostatic hypotension